Axon Enterprise shares dropped after the company announced a $1 billion convertible bond offering, a move that lets it borrow at nearly zero interest while stocking up cash, but also signals, in the fine print, that the stock may be worth less than the market currently thinks. Investors.com has the full story.

If you've never sat with a convertible bond prospectus, the plain-English version goes like this. A convertible is a loan that can turn into stock later. The lender accepts a very low interest rate, sometimes close to zero, in exchange for the right to convert the bond into shares if the stock climbs above a set price. Companies love these when regular borrowing is expensive. Axon gets a billion dollars of fuel and pays almost nothing for it.

So why did the stock fall? Two reasons, and both are worth understanding.

The first is dilution, which is just a fancy word for your slice of the pie getting smaller. If those bonds convert down the road, new shares show up and every existing share owns a little less of the company. A billion dollars' worth of eventual new shares is not a rounding error for most companies, and the market prices that in before a single bond converts.

The second reason is subtler. Convertibles are typically sold with a conversion price set above where the stock trades today, often 25 to 35 percent above. The underwriters buying this deal are betting the stock stays below that number, or they hedge accordingly, and the offering terms themselves can quietly imply that the company and its bankers see the current price as generous. When a company raises money this way at these levels, the market reads it as management saying, in effect, this is a decent price to print shares at.

I've watched this dance for decades, going back to the convertible issuance waves of the late 1990s. The mechanics never change. Cash-hungry companies selling convertibles are usually planning to spend that cash on something ambitious, and the market immediately starts arguing about whether the ambition is worth the dilution. Axon has been a growth story with a premium valuation attached to it, and premium valuations are exactly the kind that wobble when new paper shows up.

Is this a reason to panic if you own Axon? No. Companies raising cheap money to fund growth is normal, healthy capitalism. Tesla did versions of this for years and its long-term shareholders did fine. But it is a reason to remember the difference between owning a company and owning the market's opinion of a company. Axon the business just got a cheaper balance sheet. Axon the stock just got a reminder that its price rests on expectations, and expectations can be repriced in an afternoon.

This connects to something I keep repeating because it keeps being true. A single stock can absorb this kind of shock, and worse, without warning. Your index fund will wobble too, briefly, but it holds hundreds of other companies that didn't just announce a billion-dollar bond, so the damage gets averaged out instead of concentrated. Diversification, in one sentence.

One question worth asking yourself: if a stock you own fell 5 percent tomorrow on news that made the underlying business financially stronger, would you flinch? Your answer tells you a lot about whether you own individual stocks because you understand them or because they've been going up.

As usual, I'm sharing perspective built over forty years of making my own mistakes, not professional financial advice. Do your own homework, or talk to someone licensed before you act on any of it.